Clinical trial
EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease
NCT07914777 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started January 2027. Interventional study, 7,501 participants (estimated). Lead sponsor NYU Langone Health; United States. Primary measure: Percentage of patients indicated for statin therapy who were prescribed a guideline-approved statin...
How it compares
370 similar trials: same condition (Atherosclerosis) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- May 31, 2028
- Enrollment
- 7,501 (estimated)
- Sites
- 1
Conditions
MeSH condition names; the registry's own terms follow.
Registry terms: atherosclerotic cardiovascular disease
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 75 Years
- Healthy volunteers
- Yes
- Study type
- Interventional
- Sites
- 1
- Countries
- United States
- Lead sponsor
- NYU Langone Health
Arms
As registered; 3 arms.
| Arm | Type | Interventions |
|---|---|---|
| Provider | Experimental | EHR Nudge |
Show registry wordingProviders will be randomly assigned into 1 of 31 conditions. Each condition will have a unique combination of nudges A-E. | ||
| Control | No intervention | |
Show registry wordingProviders randomized to this arm will receive no EHR nudges. | ||
| Patient | Experimental | EHR Nudge |
Show registry wordingPatients will be randomly assigned into 1 of 31 conditions. Each condition will have a unique combination of nudges A-E. | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Percentage of patients indicated for statin therapy who were prescribed a guideline-approved statin at the correct dose during the study period | Month 18 |
Lead sponsor's other trials
NYU Langone Health, most recent start first.
+1,425 more trials See the organization page
Similar trials
Same condition (Atherosclerosis) and phase, most recent start first.
+365 more trials See the condition page